Welcome to our dedicated page for Medical Prop SEC filings (Ticker: MPW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Searching for "Medical Properties Trust SEC filings explained simply"? Operating a hospital REIT means every 10-K is packed with rent coverage ratios, operator credit metrics and lease escalation clauses—details that make Medical Properties Trust (MPW) disclosures especially dense for investors who just want to know whether cash flow is secure. Stock Titan’s AI reads each document the moment it hits EDGAR and turns the legalese into plain English.
Need the latest Medical Properties Trust quarterly earnings report 10-Q filing or yesterday’s 8-K on tenant restructuring? They’re here, alongside:
- Medical Properties Trust insider trading Form 4 transactions delivered in real-time
- Medical Properties Trust annual report 10-K simplified with rent coverage highlights
- Medical Properties Trust proxy statement executive compensation breakdowns
- Medical Properties Trust 8-K material events explained
- understanding Medical Properties Trust SEC documents with AI—concise summaries, red-flag alerts and side-by-side historical comparisons
Whether you’re tracking Medical Properties Trust Form 4 insider transactions real-time before dividend announcements, assessing operator liquidity through a Medical Properties Trust earnings report filing analysis, or learning how sale-leasebacks flow through the balance sheet, our platform keeps every answer a click away. Comprehensive coverage, AI-powered summaries and instant alerts mean you spend minutes—not hours—extracting insights that drive decisions.
Medical Properties Trust, Inc. (MPW) – Form 4 filing, 8 Jul 2025
Chairman, President & CEO Edward K. Aldag Jr. reported a routine, non-open-market transaction coded “F,” indicating tax withholding on the vesting of restricted stock. The company withheld 117,161 common shares at an implied price of $4.35 per share to cover statutory taxes. After the withholding, Aldag continues to directly own 5,354,656 MPW shares. No derivative securities were involved, and there were no open-market purchases or sales. The filing does not signal a change in Aldag’s overall ownership strategy or the company’s fundamentals.
- Transaction type: Code F (tax withholding, not a voluntary sale)
- Shares withheld: 117,161 (≈2.2 % of Aldag’s post-transaction holdings)
- Remaining direct holdings: 5,354,656 shares
- No new options, warrants, or derivatives disclosed
The action is administrative and generally viewed as neutral from a market-impact perspective.
Medical Properties Trust, Inc. (MPW) – Form 4 filing, 8 Jul 2025
Chairman, President & CEO Edward K. Aldag Jr. reported a routine, non-open-market transaction coded “F,” indicating tax withholding on the vesting of restricted stock. The company withheld 117,161 common shares at an implied price of $4.35 per share to cover statutory taxes. After the withholding, Aldag continues to directly own 5,354,656 MPW shares. No derivative securities were involved, and there were no open-market purchases or sales. The filing does not signal a change in Aldag’s overall ownership strategy or the company’s fundamentals.
- Transaction type: Code F (tax withholding, not a voluntary sale)
- Shares withheld: 117,161 (≈2.2 % of Aldag’s post-transaction holdings)
- Remaining direct holdings: 5,354,656 shares
- No new options, warrants, or derivatives disclosed
The action is administrative and generally viewed as neutral from a market-impact perspective.
Medical Properties Trust, Inc. (MPW) – Form 4 filing, 8 Jul 2025
Chairman, President & CEO Edward K. Aldag Jr. reported a routine, non-open-market transaction coded “F,” indicating tax withholding on the vesting of restricted stock. The company withheld 117,161 common shares at an implied price of $4.35 per share to cover statutory taxes. After the withholding, Aldag continues to directly own 5,354,656 MPW shares. No derivative securities were involved, and there were no open-market purchases or sales. The filing does not signal a change in Aldag’s overall ownership strategy or the company’s fundamentals.
- Transaction type: Code F (tax withholding, not a voluntary sale)
- Shares withheld: 117,161 (≈2.2 % of Aldag’s post-transaction holdings)
- Remaining direct holdings: 5,354,656 shares
- No new options, warrants, or derivatives disclosed
The action is administrative and generally viewed as neutral from a market-impact perspective.
Medical Properties Trust, Inc. (MPW) – Form 4 filing, 8 Jul 2025
Chairman, President & CEO Edward K. Aldag Jr. reported a routine, non-open-market transaction coded “F,” indicating tax withholding on the vesting of restricted stock. The company withheld 117,161 common shares at an implied price of $4.35 per share to cover statutory taxes. After the withholding, Aldag continues to directly own 5,354,656 MPW shares. No derivative securities were involved, and there were no open-market purchases or sales. The filing does not signal a change in Aldag’s overall ownership strategy or the company’s fundamentals.
- Transaction type: Code F (tax withholding, not a voluntary sale)
- Shares withheld: 117,161 (≈2.2 % of Aldag’s post-transaction holdings)
- Remaining direct holdings: 5,354,656 shares
- No new options, warrants, or derivatives disclosed
The action is administrative and generally viewed as neutral from a market-impact perspective.
Medical Properties Trust, Inc. (MPW) – Form 4 filing, 8 Jul 2025
Chairman, President & CEO Edward K. Aldag Jr. reported a routine, non-open-market transaction coded “F,” indicating tax withholding on the vesting of restricted stock. The company withheld 117,161 common shares at an implied price of $4.35 per share to cover statutory taxes. After the withholding, Aldag continues to directly own 5,354,656 MPW shares. No derivative securities were involved, and there were no open-market purchases or sales. The filing does not signal a change in Aldag’s overall ownership strategy or the company’s fundamentals.
- Transaction type: Code F (tax withholding, not a voluntary sale)
- Shares withheld: 117,161 (≈2.2 % of Aldag’s post-transaction holdings)
- Remaining direct holdings: 5,354,656 shares
- No new options, warrants, or derivatives disclosed
The action is administrative and generally viewed as neutral from a market-impact perspective.
Medical Properties Trust, Inc. (MPW) – Form 4 filing, 8 Jul 2025
Chairman, President & CEO Edward K. Aldag Jr. reported a routine, non-open-market transaction coded “F,” indicating tax withholding on the vesting of restricted stock. The company withheld 117,161 common shares at an implied price of $4.35 per share to cover statutory taxes. After the withholding, Aldag continues to directly own 5,354,656 MPW shares. No derivative securities were involved, and there were no open-market purchases or sales. The filing does not signal a change in Aldag’s overall ownership strategy or the company’s fundamentals.
- Transaction type: Code F (tax withholding, not a voluntary sale)
- Shares withheld: 117,161 (≈2.2 % of Aldag’s post-transaction holdings)
- Remaining direct holdings: 5,354,656 shares
- No new options, warrants, or derivatives disclosed
The action is administrative and generally viewed as neutral from a market-impact perspective.
FAQ
What is the current stock price of Medical Prop (MPW)?
What is the market cap of Medical Prop (MPW)?
What is the primary business of Medical Properties Trust, Inc.?
How does MPW generate revenue?
Which markets does Medical Properties Trust, Inc. operate in?
What is the significance of the net lease structure in MPW's business model?
How does MPW support hospital operators beyond property management?
What differentiates MPW from other real estate investment trusts?
How does Medical Properties Trust, Inc. maintain its market position?
What are the key benefits for investors considering MPW?
